Abstract: AIM: To evaluate the clinical efficacy and safety of the fuyantai pellets in treatment of patients with chronic pelvic inflammation.METHODS: 222 sub-jects were involved in a multi-center, randomized, dou-ble-blinded, double-simulation, and positive drug paral-lel-controlled clinical trail. 113 patients were enrolled in the fuyantai-pellets group, while 109 cases were enrolled in the control group.RESULTS: The total effective rate in fuyantai pellet group was better than that in the control group (P<0.05). CONCLUSION: Fuyantai pellets is an effective and safe drug in treatment of patients with chronic pelvic inflammation.

Key words: fuyantai pellet, chronic pelvic inflam-mation, TCM therapy, clinical trial